Abiopharma

(99% Neutral) GRI BIO, INC. (GRI) Files Form 8-K

CytoDyn Inc. (CYDY) Files Form 10-Q

Clene Announces Registered Direct Offering of Over $28 Million

Evolus - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

Royalty Pharma Announces Dividend Increase

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”

Clene Announces Registered Direct Offering of Over $28 Million

Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

DEFM14A (Proxy Statement - Merger or Acquistion (definitive)) SEC Filing

(80% Positive) APTEVO THERAPEUTICS INC. (APVO) Announces Clinical Development Update

New Form DEFM14A - EXACT SCIENCES CORP Filed: 2026-01-09 AccNo: 0001193125-26-008315 Size: 1 MB

New Form SCHEDULE 13D/A - EXICURE, INC. Filed: 2026-01-09 AccNo: 0002046701-26-000003 Size: 9 KB

(10% Negative) INTELLIA THERAPEUTICS, INC. (NTLA) Files Form 8-K